| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Revenue | $22.9M | +37.4% |
| Cost of Revenue | $20.1M | +33.8% |
| Gross Profit | $2.8M | +70.9% |
| R&D Expense | $923K | +67.2% |
| SG&A Expense | $5.3M | +24.3% |
| Operating Income | -$4.9M | -15.2% |
| Interest Expense | $170K | -37.8% |
| Pre-tax Income | -$4.9M | -12.8% |
| Net Income | -$4.9M |
| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $462K | -45.7% |
| Accounts Receivable | $4.9M | +18.9% |
| Inventory | $1K | +0.4% |
| Current Assets | $10.2M | +43.7% |
| Total Assets | $10.4M | +41.2% |
| Current Liabilities | $5.3M | +28.4% |
| Total Liabilities | $5.3M | +1.0% |
| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.8M | -36.9% |
| Capital Expenditures | $14K | -15.3% |
| Investing Cash Flow | -$26K | +89.1% |
| Financing Cash Flow | $5.4M | +4.6% |
| Free Cash Flow | -$5.9M | -36.7% |
| -12.8% |
| EPS (Basic) | -$0.12 | +7.7% |
| EPS (Diluted) | -$0.12 | +7.7% |
| Stockholders' Equity |
| $5.1M |
| +141.0% |